BillionToOne saw rapid growth in molecular diagnostics, strong Q3 results, and evolving valuation. Read here for more ...
Self-represented prisoners face significant disadvantages when seeking justice through conviction integrity units, with some ...
Sally and Steve Holt were clinically extremely vulnerable during the pandemic. But six years later they are still shielding, and only leaving the house for medical appointments ...
Morning Overview on MSN
New tool exposes hidden cancer networks inside tumors
Cancer has long been treated as a mass of rogue cells, but the real power lies in the intricate communication networks ...
The latest recall of bagged shrimp comes four months after the U.S. Food and Drug Administration (FDA) initially shared a ...
Our film critic looks at the films that should have made their directors household names among global audiences, but instead ...
Tesamorelin is a synthetic 44–amino acid analog of growth hormone–releasing hormone (GHRH) that has attracted attention outside the experimental domain for its potential as a research tool. This ...
The benchmark S&P 500 hit its latest record, setting up Wall Street to ride into the Christmas holiday on a high note.
SmartFinancial on MSN
Safest car brands: How higher safety ratings can impact your insurance
The safest car brands offer models that not only keep you and your passengers safe in various types of collisions but also include numerous safety features that help prevent accidents in the first ...
Olema Pharmaceuticals (OLMA) earns a "Strong Buy" rating, driven by advancing palazestrant for 1st-line ER+/HER2- metastatic ...
Live Science on MSN
New tests could nearly halve the rate of late-stage cancers, some scientists say — is that true?
The study suggests the tests could save lives by catching cancer at earlier stages, when it's more easily treated. It predicted that, over a decade of use, MCEDs could reduce stage IV cancer diagnoses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results